Literature DB >> 27153172

Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.

Sivashanmugam Dhandapani1,2, Harminder Singh1,3, Hazem M Negm1,4, Salomon Cohen1,5, Mark M Souweidane1, Jeffrey P Greenfield1, Vijay K Anand6, Theodore H Schwartz1,6,7.   

Abstract

OBJECTIVE Craniopharyngiomas can be difficult to remove completely based on their intimate relationship with surrounding visual and endocrine structures. Reoperations are not uncommon but have been associated with higher rates of complications and lower extents of resection. So radiation is often offered as an alternative to reoperation. The endonasal endoscopic transsphenoidal approach has been used in recent years for craniopharyngiomas previously removed with craniotomy. The impact of this approach on reoperations has not been widely investigated. METHODS The authors reviewed a prospectively acquired database of endonasal endoscopic resections of craniopharyngiomas over 11 years at Weill Cornell Medical College, NewYork-Presbyterian Hospital, performed by the senior authors. Reoperations were separated from first operations. Pre- and postoperative visual and endocrine function, tumor size, body mass index (BMI), quality of life (QOL), extent of resection (EOR), impact of prior radiation, and complications were compared between groups. EOR was divided into gross-total resection (GTR, 100%), near-total resection (NTR, > 95%), and subtotal resection (STR, < 95%). Univariate and multivariate analyses were performed. RESULTS Of the total 57 endonasal surgical procedures, 22 (39%) were reoperations. First-time operations and reoperations did not differ in tumor volume, radiological configuration, or patients' BMI. Hypopituitarism and diabetes insipidus (DI) were more common before reoperations (82% and 55%, respectively) compared with first operations (60% and 8.6%, respectively; p < 0.001). For the 46 patients in whom GTR was intended, rates of GTR and GTR+NTR were not significantly different between first operations (90% and 97%, respectively) and reoperations (80% and 100%, respectively). For reoperations, prior radiation and larger tumor volume had lower rates of GTR. Vision improved equally in first operations (80%) compared with reoperations (73%). New anterior pituitary deficits were more common in first operations compared with reoperations (51% vs 23%, respectively; p = 0.08), while new DI was more common in reoperations compared with first-time operations (80% vs 47%, respectively; p = 0.08). Nonendocrine complications occurred in 2 (3.6%) first-time operations and no reoperations. Tumor regrowth occurred in 6 patients (11%) over a median follow-up of 46 months and was not different between first versus reoperations, but was associated with STR (33%) compared with GTR+NTR (4%; p = 0.02) and with not receiving radiation after STR (67% vs 22%; p = 0.08). The overall BMI increased significantly from 28.7 to 34.8 kg/m2 over 10 years. Six months after surgery, there was a significant improvement in QOL, which was similar between first-time operations and reoperations, and negatively correlated with STR. CONCLUSIONS Endonasal endoscopic transsphenoidal reoperation results in similar EOR, visual outcome, and improvement in QOL as first-time operations, with no significant increase in complications. EOR is more impacted by tumor volume and prior radiation. Reoperations should be offered to patients with recurrent craniopharyngiomas and may be preferable to radiation in patients in whom GTR or NTR can be achieved.

Entities:  

Keywords:  ASBS-Q = anterior skull base surgery questionnaire; BMI = body mass index; DI = diabetes insipidus; EOR = extent of resection; GTR = gross-total resection; IQR = interquartile range; NTR = near-total resection; OR = odds ratio; PRL = prolactin; QOL = quality of life; STR = subtotal resection; craniopharyngioma; endonasal; endoscope; minimally invasive; oncology; radiation; recurrence; reoperation; skull base; surgery

Mesh:

Year:  2016        PMID: 27153172     DOI: 10.3171/2016.1.JNS152238

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

Review 1.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

2.  Prevalence and Trends in the Neuropsychological Burden of Patients having Intracranial Tumors with Respect to Neurosurgical Intervention.

Authors:  Manju Dhandapani; Sandhya Gupta; Manju Mohanty; Sunil Kumar Gupta; Sivashanmugam Dhandapani
Journal:  Ann Neurosci       Date:  2017-05-12

Review 3.  Update on management of craniopharyngiomas.

Authors:  Fraser Henderson; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

4.  Comparison of Outcomes following Primary and Repeat Resection of Craniopharyngioma.

Authors:  Alexander A Aabedi; Jacob S Young; Ryan R L Phelps; Ethan A Winkler; Michael W McDermott; Philip V Theodosopoulos
Journal:  J Neurol Surg B Skull Base       Date:  2021-09-10

5.  Reirradiation for recurrent craniopharyngioma.

Authors:  Sarah J Foran; Normand Laperriere; Kim Edelstein; Laura Janzen; Tony Tadic; Vijay Ramaswamy; David Shultz; Fred Gentili; Eric Bouffet; Derek S Tsang
Journal:  Adv Radiat Oncol       Date:  2020-08-07

6.  BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.

Authors:  Emanuele La Corte; Iyan Younus; Francesca Pivari; Adelina Selimi; Malte Ottenhausen; Jonathan A Forbes; David J Pisapia; Georgiana A Dobri; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

7.  Clinicopathological Features of Craniopharyngioma: A 15-Year Study From a Tertiary Care Center in Pakistan.

Authors:  Saroona Haroon; Anoshia Afzal; Shamail Zia; Syed J Ali; Fazail Zia; Farozaan Shamail; Muhammad Irfan; Atif A Hashmi
Journal:  Cureus       Date:  2021-03-28

Review 8.  Midline Skull Base Meningiomas: Transcranial and Endonasal Perspectives.

Authors:  Ciro Mastantuoni; Luigi Maria Cavallo; Felice Esposito; Elena d'Avella; Oreste de Divitiis; Teresa Somma; Andrea Bocchino; Gianluca Lorenzo Fabozzi; Paolo Cappabianca; Domenico Solari
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

9.  Development and Validation of Predicting Nomograms for Craniopharyngioma: A Retrospective, Multiple-Center, Cohort Study.

Authors:  Dingkang Xu; Qingjie Wei; Zhe Li; Yan Hu; Peizhu Hu; Shengqi Zhao; Dengpan Song; Shixiong Lei; Mingchu Zhang; Qiang Gao; Longxiao Zhang; Fangbo Lin; Yuchao Zuo; Xianzhi Liu; Mengzhao Feng; Chunxiao Ma; Fuyou Guo
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

10.  Expanded Transsphenoidal Trans-Lamina Terminalis Approach to Tumors Extending Into the Third Ventricle: Technique Notes and a Single Institute Experience.

Authors:  Lei Cao; Wentao Wu; Jie Kang; Hui Qiao; Xiaocui Yang; Jiwei Bai; Haibo Zhu; Yazhuo Zhang; Songbai Gui
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.